Copyright Reports & Markets. All rights reserved.

Global Dermatology Drugs Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Dermatology Drugs Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Dermatology Drugs Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Dermatology Drugs Market Size Growth Rate by Type
    • 1.4.2 External Use
    • 1.4.3 Oral
    • 1.4.4 Injection
  • 1.5 Market by Application
    • 1.5.1 Global Dermatology Drugs Market Size Growth Rate by Application
    • 1.5.2 Psoriasis
    • 1.5.3 Skin Infections
    • 1.5.4 Acne
    • 1.5.5 Dermatitis
    • 1.5.6 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Dermatology Drugs Market Size, Estimates and Forecasts
    • 2.1.1 Global Dermatology Drugs Revenue 2015-2026
    • 2.1.2 Global Dermatology Drugs Sales 2015-2026
  • 2.2 Global Dermatology Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Dermatology Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Dermatology Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Dermatology Drugs Competitor Landscape by Players

  • 3.1 Dermatology Drugs Sales by Manufacturers
    • 3.1.1 Dermatology Drugs Sales by Manufacturers (2015-2020)
    • 3.1.2 Dermatology Drugs Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Dermatology Drugs Revenue by Manufacturers
    • 3.2.1 Dermatology Drugs Revenue by Manufacturers (2015-2020)
    • 3.2.2 Dermatology Drugs Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Dermatology Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Dermatology Drugs Revenue in 2019
    • 3.2.5 Global Dermatology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Dermatology Drugs Price by Manufacturers
  • 3.4 Dermatology Drugs Manufacturing Base Distribution, Product Types
    • 3.4.1 Dermatology Drugs Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Dermatology Drugs Product Type
    • 3.4.3 Date of International Manufacturers Enter into Dermatology Drugs Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Dermatology Drugs Market Size by Type (2015-2020)
    • 4.1.1 Global Dermatology Drugs Sales by Type (2015-2020)
    • 4.1.2 Global Dermatology Drugs Revenue by Type (2015-2020)
    • 4.1.3 Dermatology Drugs Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Dermatology Drugs Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Dermatology Drugs Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Dermatology Drugs Revenue Forecast by Type (2021-2026)
    • 4.2.3 Dermatology Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Dermatology Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Dermatology Drugs Market Size by Application (2015-2020)
    • 5.1.1 Global Dermatology Drugs Sales by Application (2015-2020)
    • 5.1.2 Global Dermatology Drugs Revenue by Application (2015-2020)
    • 5.1.3 Dermatology Drugs Price by Application (2015-2020)
  • 5.2 Dermatology Drugs Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Dermatology Drugs Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Dermatology Drugs Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Dermatology Drugs Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Dermatology Drugs by Country
    • 6.1.1 North America Dermatology Drugs Sales by Country
    • 6.1.2 North America Dermatology Drugs Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Dermatology Drugs Market Facts & Figures by Type
  • 6.3 North America Dermatology Drugs Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Dermatology Drugs by Country
    • 7.1.1 Europe Dermatology Drugs Sales by Country
    • 7.1.2 Europe Dermatology Drugs Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Dermatology Drugs Market Facts & Figures by Type
  • 7.3 Europe Dermatology Drugs Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Dermatology Drugs by Region
    • 8.1.1 Asia Pacific Dermatology Drugs Sales by Region
    • 8.1.2 Asia Pacific Dermatology Drugs Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Dermatology Drugs Market Facts & Figures by Type
  • 8.3 Asia Pacific Dermatology Drugs Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Dermatology Drugs by Country
    • 9.1.1 Latin America Dermatology Drugs Sales by Country
    • 9.1.2 Latin America Dermatology Drugs Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Dermatology Drugs Market Facts & Figures by Type
  • 9.3 Central & South America Dermatology Drugs Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Dermatology Drugs by Country
    • 10.1.1 Middle East and Africa Dermatology Drugs Sales by Country
    • 10.1.2 Middle East and Africa Dermatology Drugs Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Dermatology Drugs Market Facts & Figures by Type
  • 10.3 Middle East and Africa Dermatology Drugs Market Facts & Figures by Application

11 Company Profiles

  • 11.1 AbbVie
    • 11.1.1 AbbVie Corporation Information
    • 11.1.2 AbbVie Description and Business Overview
    • 11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 AbbVie Dermatology Drugs Products Offered
    • 11.1.5 AbbVie Related Developments
  • 11.2 Johnson & Johnson
    • 11.2.1 Johnson & Johnson Corporation Information
    • 11.2.2 Johnson & Johnson Description and Business Overview
    • 11.2.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Johnson & Johnson Dermatology Drugs Products Offered
    • 11.2.5 Johnson & Johnson Related Developments
  • 11.3 Bayer
    • 11.3.1 Bayer Corporation Information
    • 11.3.2 Bayer Description and Business Overview
    • 11.3.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Bayer Dermatology Drugs Products Offered
    • 11.3.5 Bayer Related Developments
  • 11.4 Galderma
    • 11.4.1 Galderma Corporation Information
    • 11.4.2 Galderma Description and Business Overview
    • 11.4.3 Galderma Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Galderma Dermatology Drugs Products Offered
    • 11.4.5 Galderma Related Developments
  • 11.5 Bristol-Myers Squibb
    • 11.5.1 Bristol-Myers Squibb Corporation Information
    • 11.5.2 Bristol-Myers Squibb Description and Business Overview
    • 11.5.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Bristol-Myers Squibb Dermatology Drugs Products Offered
    • 11.5.5 Bristol-Myers Squibb Related Developments
  • 11.6 Novartis
    • 11.6.1 Novartis Corporation Information
    • 11.6.2 Novartis Description and Business Overview
    • 11.6.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Novartis Dermatology Drugs Products Offered
    • 11.6.5 Novartis Related Developments
  • 11.7 Pfizer
    • 11.7.1 Pfizer Corporation Information
    • 11.7.2 Pfizer Description and Business Overview
    • 11.7.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Pfizer Dermatology Drugs Products Offered
    • 11.7.5 Pfizer Related Developments
  • 11.8 Merz Pharma
    • 11.8.1 Merz Pharma Corporation Information
    • 11.8.2 Merz Pharma Description and Business Overview
    • 11.8.3 Merz Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Merz Pharma Dermatology Drugs Products Offered
    • 11.8.5 Merz Pharma Related Developments
  • 11.9 Bausch Health Companies Inc
    • 11.9.1 Bausch Health Companies Inc Corporation Information
    • 11.9.2 Bausch Health Companies Inc Description and Business Overview
    • 11.9.3 Bausch Health Companies Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Bausch Health Companies Inc Dermatology Drugs Products Offered
    • 11.9.5 Bausch Health Companies Inc Related Developments
  • 11.10 LEO Pharma
    • 11.10.1 LEO Pharma Corporation Information
    • 11.10.2 LEO Pharma Description and Business Overview
    • 11.10.3 LEO Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 LEO Pharma Dermatology Drugs Products Offered
    • 11.10.5 LEO Pharma Related Developments
  • 11.1 AbbVie
    • 11.1.1 AbbVie Corporation Information
    • 11.1.2 AbbVie Description and Business Overview
    • 11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 AbbVie Dermatology Drugs Products Offered
    • 11.1.5 AbbVie Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Dermatology Drugs Market Estimates and Projections by Region
    • 12.1.1 Global Dermatology Drugs Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Dermatology Drugs Revenue Forecast by Regions 2021-2026
  • 12.2 North America Dermatology Drugs Market Size Forecast (2021-2026)
    • 12.2.1 North America: Dermatology Drugs Sales Forecast (2021-2026)
    • 12.2.2 North America: Dermatology Drugs Revenue Forecast (2021-2026)
    • 12.2.3 North America: Dermatology Drugs Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Dermatology Drugs Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Dermatology Drugs Sales Forecast (2021-2026)
    • 12.3.2 Europe: Dermatology Drugs Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Dermatology Drugs Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Dermatology Drugs Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Dermatology Drugs Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Dermatology Drugs Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Dermatology Drugs Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Dermatology Drugs Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Dermatology Drugs Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Dermatology Drugs Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Dermatology Drugs Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Dermatology Drugs Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Dermatology Drugs Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Dermatology Drugs Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Dermatology Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Dermatology Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Dermatology Drugs Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Dermatology Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Dermatology Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Dermatology Drugs market is segmented into
    External Use
    Oral
    Injection

    Segment by Application, the Dermatology Drugs market is segmented into
    Psoriasis
    Skin Infections
    Acne
    Dermatitis
    Other

    Regional and Country-level Analysis
    The Dermatology Drugs market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Dermatology Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Dermatology Drugs Market Share Analysis
    Dermatology Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Dermatology Drugs business, the date to enter into the Dermatology Drugs market, Dermatology Drugs product introduction, recent developments, etc.

    The major vendors covered:
    AbbVie
    Johnson & Johnson
    Bayer
    Galderma
    Bristol-Myers Squibb
    Novartis
    Pfizer
    Merz Pharma
    Bausch Health Companies Inc
    LEO Pharma
    GlaxoSmithKline

    Buy now